Literature DB >> 10951205

Mitochondrial and submitochondrial localization of human deoxyguanosine kinase.

M Jüllig1, S Eriksson.   

Abstract

Deoxyguanosine kinase and thymidine kinase 2 are responsible for catalysing the first step in the salvage of deoxynucleosides in mitochondria. These enzymes also play an important role in activating several antiviral and anticancer nucleoside analogs, which may lead to unwanted side-effects when the resulting nucleotides are incorporated into the mitochondrial genome. We studied deoxyguanosine kinase in submitochondrial fractions from human placental mitochondria. It was localized in the mitochondrial matrix fraction by Western blotting using a purified polyclonal antibody. This antibody was also used in an immunohistochemical in situ experiment with human embryonic kidney 293 cells, in which the deoxyguanosine kinase antibody colocalized with a mitochondrion-specific fluorescent probe and there was no significant cytosolic staining.

Entities:  

Mesh:

Year:  2000        PMID: 10951205     DOI: 10.1046/j.1432-1327.2000.01607.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Antiviral guanosine analogs as substrates for deoxyguanosine kinase: implications for chemotherapy.

Authors:  A Herrström Sjöberg; L Wang; S Eriksson
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines.

Authors:  Wolfgang Knecht; Michael P B Sandrini; Kenth Johansson; Hans Eklund; Birgitte Munch-Petersen; Jure Piskur
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

3.  [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.

Authors:  Woosuk Kim; Thuc M Le; Liu Wei; Soumya Poddar; Jimmy Bazzy; Xuemeng Wang; Nhu T Uong; Evan R Abt; Joseph R Capri; Wayne R Austin; Juno S Van Valkenburgh; Dalton Steele; Raymond M Gipson; Roger Slavik; Anthony E Cabebe; Thotsophon Taechariyakul; Shahriar S Yaghoubi; Jason T Lee; Saman Sadeghi; Arnon Lavie; Kym F Faull; Owen N Witte; Timothy R Donahue; Michael E Phelps; Harvey R Herschman; Ken Herrmann; Johannes Czernin; Caius G Radu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

Review 4.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 5.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

6.  Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.

Authors:  Paula Garcia-Esparcia; Irene López-González; Oriol Grau-Rivera; María Francisca García-Garrido; Anusha Konetti; Franc Llorens; Saima Zafar; Margarita Carmona; José Antonio Del Rio; Inga Zerr; Ellen Gelpi; Isidro Ferrer
Journal:  Front Neurol       Date:  2017-03-13       Impact factor: 4.003

7.  Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions.

Authors:  Dario Ronchi; Caterina Garone; Andreina Bordoni; Purificacion Gutierrez Rios; Sarah E Calvo; Michela Ripolone; Michela Ranieri; Mafalda Rizzuti; Luisa Villa; Francesca Magri; Stefania Corti; Nereo Bresolin; Vamsi K Mootha; Maurizio Moggio; Salvatore DiMauro; Giacomo P Comi; Monica Sciacco
Journal:  Brain       Date:  2012-10-04       Impact factor: 13.501

Review 8.  Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA.

Authors:  Joanna Rusecka; Magdalena Kaliszewska; Ewa Bartnik; Katarzyna Tońska
Journal:  J Appl Genet       Date:  2018-01-17       Impact factor: 3.240

Review 9.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.